Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2013
06/25/2013CA2402718C Fish vaccine against piscirickettsia salmonis
06/22/2013CA2762717A1 Antimicrobial agents
06/20/2013WO2013090840A1 2 -amino- pyrido [3, 2 -d] pyrimidine derivatives as hcv inhibitors
06/20/2013WO2013090644A2 Anti-hiv antibodies having increased potency and breadth
06/20/2013WO2013089721A1 Thymol and totarol antibacterial composition
06/20/2013WO2013089496A1 Broad-spectrum neutralizing monoclonal antibody having high potential derived from h1n1-infected patients, and composition containing same for treating the virus
06/20/2013WO2013089168A1 Method for producing neuraminic acid derivative
06/20/2013WO2013088389A1 Linezolid premix
06/20/2013WO2013088162A1 Antimicrobial compounds and methods
06/20/2013WO2013087794A1 Polymorph of rilpivirine hydrochloride and its use as antiviral
06/20/2013WO2013087743A1 Inhibitors of hcv ns5a
06/20/2013WO2013087727A1 New efficient interferon-based treating methods
06/20/2013WO2013087217A1 Composition for the treatment of bacterial infections
06/20/2013WO2013087043A1 Flavobacterium strain, endo-alginate lyase encoding gene, and preparation and use of said gene
06/20/2013WO2013068743A9 Novel bacteriophages
06/20/2013WO2013060744A3 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis
06/20/2013WO2013058681A3 Substituted phenoxyacetic acids and esters and amides thereof, comprising a 2,6-dioxo-2,3,6,7-tetrahydro-1н-purine-8-yl fragment and constituting а2a adenosine receptor antagonists, and the use thereof
06/20/2013WO2013056003A3 Catechol diethers as potent anti-hiv agents
06/20/2013WO2013038385A3 Escherichia coli vaccine combination
06/20/2013WO2013020164A9 Compounds for treating respiratory syncytial virus infections
06/20/2013US20130158129 Natural, multiple release and re-use compositions
06/20/2013US20130157971 2'-fluoronucleosides
06/20/2013US20130157357 Lentiviral vectors for the preparation of immunotherapeutical compositions
06/20/2013US20130156802 Cholera Toxin Chimera and its Use as a Staph Vaccine
06/20/2013US20130156775 Chlamydia trachomatis antigens
06/20/2013US20130156738 Bifidobacterium adolescentis spm0212 having antiviral activity for hepatitis b virus, and pharmaceutical composition for preventing and treating hepatitis b comprising thereof
06/20/2013US20130156712 Stable surfactant compositions for suspending components
06/20/2013US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/20/2013US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases
06/20/2013DE112011102649T5 Medikament und Verfahren zur Prävention einer HIV-Kontamination, Prävention und Behandlung von Krankheiten, die durch HIV verursacht werden, und von mit HIV zusammenhängen-den Krankheiten, einschließlich AIDS Drug and method for the prevention of HIV contamination, prevention and treatment of diseases caused by HIV, and HIV-associated diseases including AIDS
06/20/2013CA2863557A1 Process of expanding t cells
06/20/2013CA2855574A1 Inhibitors of hcv ns5a
06/20/2013CA2854209A1 Composition for the treatment of bacterial infections
06/20/2013CA2799881A1 Nasal wash solution
06/19/2013EP2604621A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604620A1 Modified fluorinated nucleoside analogues
06/19/2013EP2604619A2 Mannose derivatives as antagonists of bacterial adhesion
06/19/2013EP2604593A1 Polymorph of Rilpivirine hydrochloride and its use as antiviral
06/19/2013EP2604287A2 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604286A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604285A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604273A1 Composition for the treatment of bacterial infections
06/19/2013EP2604264A1 Pharmaceutical composition for treating viral diseases
06/19/2013EP2604263A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
06/19/2013EP2603587A1 Methods and pharmaceutical compositions for the treatment of hiv-1 infections
06/19/2013EP2603576A2 System and method for reverting antibiotic tolerance of bacterial persister cells
06/19/2013EP2603514A1 Cyclic boronic acid ester derivatives and therapeutic uses thereof
06/19/2013EP2603504A1 Hepatitis c virus inhibitors
06/19/2013EP2603237A2 Anti-hemagglutinin antibody compositions and methods of use thereof
06/19/2013EP2603234A1 Method for reducing dna impurities in viral compositions
06/19/2013EP2603229A1 Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses
06/19/2013EP2603228A1 Use of angiotensin- ii (1-7) in cell transplantation and as an agent for preventing/treating norovirus infection
06/19/2013EP2603220A1 Antisense antiviral compounds and methods for treating a filovirus infection
06/19/2013CN1950343B Basic amine compound and use thereof
06/19/2013CN1798834B Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon
06/19/2013CN103168029A Salts and polymorphs of sulfamide ns3 inhibitors
06/19/2013CN103167894A Inhibition of microbial growth by aconitase inhibition
06/19/2013CN103167881A Methods and compositions for inhibiting HIV transmission
06/19/2013CN103167877A Composition comprising glutathione reductase and oxidized glutathione, and therapeutic uses thereof
06/19/2013CN103160555A Culture medium, culture method and application of high-yield exotoxin of clostridium perfringens
06/19/2013CN103160530A Fusion gene and applications thereof
06/19/2013CN103160526A Mytilus edulis G-type lysozyme gene and recombinant protein and application thereof
06/19/2013CN103160525A Mytilus edulis G-type lysozyme gene and recombinant protein and application thereof
06/19/2013CN103160520A MiR-15a target site sequence and application of miR-15a target site sequence in restraining hepatitis B virus replication
06/19/2013CN103160519A Staphylococcus aureus enterotoxin B (SEB) immune preparation and its preparation method and use
06/19/2013CN103160477A Method for improving Japanese encephalitis virus titer
06/19/2013CN103160475A Enterovirus 71 type viral strain, its application, vaccine and preparation method
06/19/2013CN103160474A Enterovirus 71 type virus strain, vaccine, animal model establishment method
06/19/2013CN103160473A Composition for recovering measles virus, and kit, purpose and method thereof
06/19/2013CN103160371A Natural plant oil having broad-spectrum antibacterial activity and preparation method thereof
06/19/2013CN103159859A Sendai virus antigen peptide composition and application thereof in detecting Sendai virus infection
06/19/2013CN103159858A Swine fever branch peptide and application thereof
06/19/2013CN103159853A Completely humanized genetic engineering fragment antigen binding (Fab) antibody against hepatitis C virus core antigen, preparation method thereof and application
06/19/2013CN103159851A Micromolecule polypeptide preventing and restraining inflammation and application thereof
06/19/2013CN103159836A Compound biological agent for blocking human immunodeficiency virus (HIV) viruses from being replicated and being integrated with deoxyribonucleic acid (DNA) of host cell
06/19/2013CN103159834A Sendai virus antigen peptide and application thereof in detecting Sendai virus infection
06/19/2013CN103159833A Sendai virus antigen peptide and application thereof in detecting Sendai virus infection
06/19/2013CN103159830A Lipopeptide compounds
06/19/2013CN103159822A Preparation method of triptolide and ramification composition thereof
06/19/2013CN103159815A Monophosphate vidarabine crystalline compound, medical composition and preparation method thereof
06/19/2013CN103159814A Gambogic acid ester derivative as well as preparation method and use thereof
06/19/2013CN103159801A N-ferrocenyl-N'-aryl urea compound and applications thereof
06/19/2013CN103159787A Preparation method for high-purity sterilized cefotiam hydrochloride and pharmaceutical composition containing cefotiam hydrochloride
06/19/2013CN103159786A Preparation method for high-purity sterilized cefmenoxime hydrochloride and pharmaceutical composition containing cefmenoxime hydrochloride
06/19/2013CN103159785A Cefuroxime lysine and preparation thereof
06/19/2013CN103159784A Cefuroxime lysine and preparation thereof
06/19/2013CN103159770A Crystal form of ertapenem monosodium salt
06/19/2013CN103159754A Amino propyl replacing tropane amine compound, medical composition thereof, preparation method and purpose thereof
06/19/2013CN103159737A Esomeprazole sodium compound and medicine composition
06/19/2013CN103159733A Thiophene methanamide compound with NDM-1 inhibitory activity
06/19/2013CN103159721A 8-epi-12-epi-isoandrographolidume-19-sulfate, preparation method and purposes of prepared medicine
06/19/2013CN103159720A 8-epi-isoandrographolidume-19-sulfate, preparation method and purposes of prepared medicine
06/19/2013CN103159717A 17-hydrogen-9-dehydro-andrographolidume-3, 19-disulfate, preparation method and purposes of medicine prepared by the same
06/19/2013CN103159716A 17-hydrogen-9-dehydro-andrographolidume-3-disulfate, preparation method and purposes of prepared medicine
06/19/2013CN103159715A 17-hydrogen-9-dehydro-andrographolidume-14-sulfate, preparation method and purposes of medicine prepared by the same
06/19/2013CN103159714A 17-hydrogen-9-dehydro-andrographolidume-19-sulfate, preparation method and purposes of medicine prepared by the same
06/19/2013CN103159713A Composite of 17-hydrogen-9-dehydro-andrographolidume-3, 19-sodium (or potassium) disulfate and 17-hydrogen-9-dehydro-andrographolidume-19-sodium (or potassium) disulfate, and purposes of medicine prepared by the same
06/19/2013CN103159712A Compound of 17-hydrogen-9-dehydrogenation andrographolide-3-sulphate sodium (or potassium) and 17-hydrogen-9-dehydrogenation andrographolide-3, 19-disulfate sodium (or potassium) and preparation drug purposes thereof
06/19/2013CN103159711A Once preparation method of composite of 17-hydrogen-9-dehydro-andrographolidume-3, 19-sodium (or potassium) disulfate and 17-hydrogen-9-dehydro-andrographolidume-19-sodium (or potassium) disulfate, and purposes of prepared medicine
06/19/2013CN103159710A Antiviral decalin derivate
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 1798